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1Division of Vector-Borne Infectious Diseases, National Center 
for Infectious Diseases, Centers for Disease Control and Prevention, 
Fort Collins, Colorado; Departments of2Biochemistry and Molecular 
Biology and 3 Medicine, Division of Infectious Diseases, 
New York Medical College, Valhalla 
Erythematous rashes that are suggestive of early Lyme disease have been associated with 
the bite of Amblyomma americanum ticks, particularly in the southern United States. However, 
Borrelia burgdorferi, the causative agent of Lyme disease, has not been cultured from skin 
biopsy specimens from these patients, and diagnostic serum antibodies usually have not been 
found. Borrelia lonestari sp nov, an uncultured spirochete, has been detected in A. americanum 
ticks by DNA amplification techniques, but its role in human illness is unknown. We observed 
erythema migrans in a patient with an attached A. americanum tick. DNA amplification of 
the flagellin geneflaB produced B. lonestari sequences from the skin of the patient that were 
identical to those found in the attached tick. B. lonestari is a probable cause of erythema 
migrans in humans. 
Borrelia burgdorferi sensu stricto, which is transmitted by 
ticks of the subgenus Ixodes, is the only established cause of 
Lyme disease in North America [1]. In the United States, most 
persons acquire Lyme disease in the northeastern or north cen- 
tral regions or in the Pacific Northwest; however, each year 
hundreds of patients from southeastern and south central states 
are reported to have this illness [2]. Several publications on 
suspected Lyme disease in southern states describe patients with 
a mild illness characterized by an erythema migrans rash that 
develops at the site of a bite by Amblyomma americanum, the 
lone star tick [3-6]. Despite the existence of B. burgdorferi in 
enzootic cycles in southern states, human B. burgdorferi infec- 
tion acquired in this area has not been confirmed by culture 
from clinical specimens. In addition, serologic tests rarely in- 
dicate exposure to this organism [3, 4, 6]. 
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A. americanum is the species of tick that most commonly 
bites humans in the southeastern and south central United 
States. It is distributed from central Texas and Oklahoma east- 
ward across the southern states and along the Atlantic coast 
as far north as Maine [7, 8]. In the laboratory, A. americanum 
is an incompetent vector for B. burgdorferi sensu stricto. How- 
ever, several studies have demonstrated that l07o-307o f A. 
americanum ticks are infected with a spirochete [9]. Although 
this spirochete has not yet been cultured, phylogenetic analysis 
of amplified DNA sequences has shown that it differs from all 
borrelial species known to cause Lyme disease [9, 10]. Barbour 
et al. [9] demonstrated by analysis of 16S rRNA sequences that 
it is more closely related to the relapsing fever spirochetes Bor- 
relia miyamotoi sp nov in Japan and to an unnamed Borrelia 
species isolated from dogs in Florida. They proposed the name 
Borrelia lonestari sp nov. Whether A. americanum ticks can 
transmit B. lonestari to humans or whether B. lonestari causes 
clinical illness has not been determined. 
We describe a patient with erythema migrans at the site of 
an attached lone star tick and at a secondary site, after recent 
travel to Maryland and North Carolina. Clinical specimens and 
the tick were evaluated for evidence of infection by Borrelia, 
using polymerase chain reaction (PCR), culture, and serologic 
tests. 
Case Report 
A 74-year-old African American man was evaluated on 24 
May 1999 at New York Medical College (NYMC; Valhalla) 
because of an abdominal skin rash that had been present for 
~4 days, as well as fatigue, cough, and right shoulder discom- 
fort of ~1 week's duration. He denied having fever or head- 
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aches. The patient was a resident of southern Westchester 
County, New York. He traveled to Maryland on 6 May and 
then left Maryland on 6 May to travel to North Carolina, where 
he stayed from 7 May to 18 May. He returned to Maryland 
on 18 May and then left on 20 May to return to his home in 
Westchester County. He had walked in grassy areas in both 
Maryland and North Carolina. His medical history included a 
left nephrectomy in June 1998 for a renal cell carcinoma, pros- 
tate carcinoma diagnosed in 1997, colonic carcinoma resected 
in 1985, hypertension, and hypothyroidism. 
At examination, the patient had an oral temperature of 
36.80C. Results of musculoskeletal, neurologic, pulmonary, and 
cardiac examinations were normal. A 19 X 11-cm annular ery- 
thematous lesion surrounding an attached, engorged tick was 
present in the right lower quadrant of the abdomen, and a 
separate 4 X 3-cm erythematous lesion was present in the left 
upper quadrant (figure \A, \B). The patient first noticed the 
tick on 15 May but did not remove it because he thought it 
was a skin lesion. The tick was removed at NYMC on 24 May 
for taxonomic evaluation and microbiologic studies. 
Laboratory evaluation showed normal white blood cell count 
and differential, hemoglobin level, and platelet count. Results of 
analysis of serum chemistry were normal, except for an alkaline 
phosphatase level of 142 U/L (normal range, 35-110 U/L). An 
electrocardiogram showed premature atrial contractions. 
Beginning 24 May, the patient received a 14-day course of 
doxycycline (100 mg orally twice daily). The skin lesions re- 
solved by 4 June. The patient reported that he had returned to 
his usual state of health by 16 June 1999. 
Materials and Methods 
Skin biopsy and culture. On 24 May 1999, a 2-mm punch 
biopsy sample was taken from the edge of the skin lesion in the 
right lower quadrant of the abdomen, farthest from the site of tick 
attachment. The skin sample was processed at NYMC for B. burg- 
dorferi culture and PCR studies, as reported elsewhere [11]. 
Tick methods. The removed tick was identified as a female of 
the species A. americanum and was sent to the Centers for Disease 
Control and Prevention (CDC) at Fort Collins, Colorado, for fur- 
ther study. At the CDC, the tick was cut in half longitudinally. One 
half was processed for PCR, as described below, and the other half 
was processed for coculture with Ixodes scapularis embryonic cells 
(cell line IDE2; a gift from T. Kurtii, University of Minnesota, 
Minneapolis). The coculture was prepared as described by Kurtii 
et al. [12], was incubated at 3rC, and was checked by dark-field 
microscopy every week for 2 months for the presence of spirochetes. 
PCR. DNA from the skin specimen and the patient's blood 
was extracted at NYMC by using an IsoQuick nucleic acid isolation 
kit (Orca Research). Because the skin specimen had been trans- 
ported from the clinic in BSK-H medium (Sigma), DNA was pre- 
pared from both the skin itself and the medium fraction ("super- 
natant"). At the CDC, DNA from the tick was prepared by 
maceration of the tick in 1 mL of a guanidinium reagent (DNA 
STAT-60; Tel-Test) and was isolated according to the manufac- 
turer's instructions. DNA samples from the patient's skin biopsy 
specimen, skin supernatant, and blood and from the tick were 
exchanged between the NYMC and CDC laboratories, and PCR 
was done at each site. 
Nested PCR amplification with broadly-reactive flagellin gene 
(flaB) primers was done at NYMC and the CDC by using primers 
FlaLL and FlaRL in the first amplification and primers FlaLS and 
FlaRS in the second amplification, after the amplicons in the first 
product were diluted 1:100 with water. Primers, reaction condi- 
tions, and thermal cycling were as described elsewhere [9]. Speci- 
mens also were tested for the presence of B. burgdorferi DNA by 
PCR, with species-specific primers directed at the 23S rDNA du- 
plication [11], the 16S-23S rDNA spacer, and ospA [I]. In addition, 
amplification of the 16S rDNA sequence was done by using broad- 
range eubacterial primers [13] and primers based on the B. lonestari 
16S rDNA sequence [9]. 
DNA sequencing. The PCR products obtained in each labo- 
ratory from the skin-sample supernatant and the A. americanum 
tick were sequenced at the CDC after purification with a Qiagen 
PCR kit. Sequencing was done using a Taq DyeDeoxy terminator 
cycle-sequencing kit (Applied Biosystems) and was run on an Ap- 
plied Biosystems Model 373A automated sequencer. Sequences 
were obtained from both DNA strands for each sample. The B. 
lonestari flaB sequences from skin and tick DNA have been de- 
posited in GenBank (accession nos. AF273670 and AF273671). 
Serologic tests. Serum samples obtained from the patient dur- 
ing the acute (24 May) and convalescent (2 and 26 June) phases 
of illness were tested for antibodies to B. burgdorferi by an IgG/ 
IgM ELISA (Wampole Laboratories). IgM and IgG antibodies to 
B. burgdorferi were measured separately by immunoblotting, using 
serum diluted 1:100. The B. burgdorferi antigens were from strain 
B31 (low passage; CDC reference collection) grown in BSK-H me- 
dium and were fractionated (15 /ng per minigel) by discontinuous 
SDS-PAGE through 13.50Zo acrylamide gels; immunoblotting was 
done by standard procedures [1]. 
Results 
No laboratory evidence of B. burgdorferi infection was found. 
Culture of the skin biopsy sample in BSK-H medium and co- 
culture of the sample of tick cells failed to propagate B. burg- 
dorferi. Moreover, B. burgdorferi sequences were not detected 
by PCR of DNA prepared from skin, skin supernatant, or 
blood, using 3 different sets of B. burgdorferi-spGcific primers. 
Acute- and convalescent-phase serum samples were negative 
for B. burgdorferi antibody by ELISA and immunoblotting. 
No IgM bands were found to be present on immunoblots for 
B. burgdorferi antigen; only a single IgG band at the position 
of FlaB, a 41-kDa antigen, was detected in both the acute- and 
convalescent-phase serum samples (data not shown). 
In contrast, DNA evidence compatible with B. lonestari in- 
fection was obtained. Amplification of the flaB, using Borrelia 
genus-wide PCR primers, resulted in products of ~350 bp from 
both the patient (DNA from the supernatant of the skin sample) 
and the tick, at both the NYMC and the CDC (figure 2A). 
The positive control (figure 2A) was B. burgdorferi DNA from 
Figure 1. Erythema migrans of case patient and point of attachment of female Amblyomma americanum tick. A, Skin lesion with central 
clearing, in right lower quadrant of abdomen. Raised lesion marks indicate from which area the attached tick was removed. B, Skin lesion in 
left upper quadrant of abdomen, below surgical scar. 
JID 2001;183 (15 June) Borrelia lonestari Infection 1813 
A B 
M 1 2 3 4 
150 170 190 
I I I I I 1 patient & tick TAEELGMQPAKINTPASLTGAQA8WTLRVQVGANQDEAIAVNIFSTNVANLPGGEGVQAA 
B. lonestarl ------------------------------ 
B. miyamotol -------- ---------A-S H-------H------YAK--- N---A-- 
B. burgdorferl ------------- --------------T---------YAA----S---A-T- 
210 230 250 
I I I I I * 
patient & tick PAQ.. EEGAQQEGVQPAPA ...... QGGISSPINVTTAIDANASLTKIEDAIRMISDQR 
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Figure 2. Analysis of DNA from case patient and tick. A, flaB DNA amplified by polymerase chain reaction (PCR). Amplicons were separated 
by electrophoresis on a 1% agarose gel and were detected by ethidium-bromide staining. Lane M, Molecular weight markers, in 100-bp intervals; 
lane 1, negative control (water); lane 2, case patient DNA from supernatant of a skin biopsy sample; lane 3, tick DNA; lane 4, positive control 
(Borrelia burgdorferi B31 DNA). B, Deduced amino acid sequence of portion of flaB DNA amplified from both patient skin-sample supernatant 
and the attached tick. Sequences are compared with the equivalent regions of flaB from B. lonestari in ticks from New Jersey, B. miyamotoi HT31, 
and B. burgdorferi B31. GenBank accession nos. for the reference sequences are AAA99141, BAA07832, and CAA33696, respectively. *Amino 
acid position that showed sequence heterogeneity in the uncloned amplicons. Serine was deduced from the AGT sequence of tick DNA amplified 
at both New York Medical College (NYMC; Valhalla) and the Centers for Disease Control and Prevention (CDC; Fort Collins, Colorado) and 
from patient skin-sample supernatant DNA amplified at NYMC. Threonine was deduced from the ACT sequence of skin-sample supernatant 
DNA amplified at the CDC. Nos. correspond to the amino acid positions of FlaB in B. miyamotoi. 
cultured spirochetes, not from skin. During 1991-1997, we de- 
tected B. burgdorferi DNA in 65% (192 of 294) of skin biopsy 
specimens from patients with erythema migrans. It was not 
uncommon for B. burgdorferi DNA to be detected in a skin- 
sample supernatant but not in the corresponding macerated 
skin extract (I.S., unpublished data). No amplicons were de- 
tected with DNA produced from the macerated skin sample, 
from the patient's blood, or from the negative controls that 
lacked DNA. 
Sequencing of 4 PCR products, from amplicons produced 
independently in each laboratory from DNA of the skin-sample 
supernatant and of the tick, revealed that this portion offlaB 
was identical in host and vector samples, with the possible 
exception of the amino acid marked by an asterisk in figure 
2B. Sequences differed only slightly from those obtained else- 
where for B. lonestari in A. americanum ticks from New Jersey 
and Texas [9]. All sequences in this study contained an extra 
AGA at positions 330-332, compared with the published B. 
lonestari sequences (GenBank U26704-5) and 2 nucleotide dif- 
ferences near the 3' end of the amplicons. The deduced amino 
acid sequence contains an extra glutamic acid as a consequence 
of the AGA insertion at amino acid position 211 (figure 2B). 
In this study, we found 2 conservative amino acid changes near 
the carboxy terminus, an isoleucine followed by serine, com- 
pared with valine-threonine in the B. lonestari sequences in ticks 
from New Jersey. Alignment of the deduced amino acid se- 
quences obtained from the skin biopsy sample and the tick with 
the equivalent regions of FlaB from other Borrelia species con- 
firms that the sequence does not differ significantly from the 
B. lonestari sequence (figure 2B). 
Discussion 
The clinical and laboratory data from this study strongly 
suggest that A. americanum ticks transmit B. lonestari to hu- 
mans and cause an illness that is indistinguishable clinically 
from early stage Lyme disease. First, there was a temporal 
relationship between the bite of an A. americanum tick and 
erythema migrans at the site of the tick bite and at a remote 
region. Second, we identified B. lonestariflaB sequences in both 
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the tick and a skin sample obtained from the periphery of the 
skin lesion. Third, laboratory evidence (culture, PCR, and se- 
rologic tests) does not support a diagnosis of infection by B. 
burgdorferi, although the skin lesion resolved after standard 
antibiotic therapy for Lyme disease. 
Curiously, our repeated attempts to amplify 16S rDNA frag- 
ments both from the biopsy specimen and from the tick extract, 
using broad-range eubacterial and B. lonestari-spQcific primers, 
were unsuccessful. The reason for this failure is unclear, al- 
though the relatively larger PCR product expected from such 
amplification (~1400 bp vs. 350 bp) and a low number of Bor- 
relia genome equivalents in the samples may account for this 
observation. 
The validity of using flaB sequences to establish Borrelia 
taxonomy has been demonstrated elsewhere [14]. Furthermore, 
in numerous instances, sequence-based identification of a mi- 
crobe that had not been cultured provided the initial evidence 
for disease causation. Another tickborne illness, human mono- 
cytic ehrlichiosis, is a pertinent example [15]. The seminal ob- 
servations from gene sequencing of Ehrlichia chaffeensis pro- 
vided the impetus for the eventual development of culture 
methods and specific serum antibody tests. 
An important question is how many of the other reported 
cases of erythema migrans or erythema migrans-like illness in 
southern states and elsewhere in the United States are due to 
B. lonestari. A Lyme disease-like illness after a bite from an 
A. americanum tick has been reported in New Jersey [8]. Of 3 
series of patients with an illness involving a rash who were from 
the southern United States, 9Vo-\4Vo recalled a preceding tick 
bite that was consistent with that of A. americanum ticks [3, 4, 
6]. Because only adult female A. americanum ticks are likely to 
be identified by patients, these proportions should be regarded 
as minimum estimates. Masters et al. [5] have described 17 
selected patients with erythema migrans-like illness who were 
from Missouri, all of whom had a preceding bite from an A. 
americanum tick. Theoretically, B. lonestari-infGCted A. ameri- 
canum may be sympatric with B. burgdorferi-infQctQd I. scapu- 
laris, particularly in states along the eastern seaboard. This 
coexistence has been documented in New Jersey [2,8]. In such 
areas, 2 different Borrelia species may cause erythema migrans, 
and not all erythema migrans will indicate Lyme disease. 
A specific serologic test for evidence of exposure to B. lonestari 
is not yet available. We are working to develop and validate such 
a test, because it will be an important tool in determining the 
etiology of erythema migrans in individual patients and in un- 
derstanding the epidemiology of B. lonestari infections. 
In the United States, B. lonestari may be a new tickborne 
pathogen of humans. This case report suggests that efforts to 
assess the public health importance of B. lonestari infection are 
warranted. This assessment should include concerted clinical 
and epidemiologic studies and field investigations of vector ticks 
and their hosts. 
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